McKesson Snags Precision Medicine Group In $2.25B Deal
Healthcare services provider McKesson Corp., advised by Davis Polk & Wardwell LLP, on Tuesday unveiled plans to acquire clinical research and biopharmaceutical commercialization services business Precision Medicine Group for roughly $2.25...To view the full article, register now.
Already a subscriber? Click here to view full article